Clinical trial
A Phase 1b Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Intrathecally Administered ION356 in Patients With Pelizaeus Merzbacher Disease
NCT06150716 is registered in ClinicalTrials.gov with Ionis Pharmaceuticals, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1b Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Intrathecally Administered ION356 in Patients With Pelizaeus Merzbacher Disease
- Lead sponsor
- Ionis Pharmaceuticals, Inc.
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- April 10, 2024
- Completion date
- June 30, 2028
- Enrollment
- 24 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.